Approval of breast cancer treatment triggers $5M payment to Immunogen

Home › Approval of breast cancer treatment triggers $5M payment to Immunogen

Immunogen Inc., led by CEO Daniel Junius, has received a $5M milestone payment for its role in Kadcyla receiving approval in Japan.

26.11	BG
26.11	DVD 9
26.11	Happy2024 LAST BIG
26.11	1-21
26.11	A-68507
26.11	160cm
26.11	stray kids GO yes24
26.11	mark borthwick whats bummer zine edition
More »

je.st